About Rkayson Pharma Private Limited
Data last updated:
Rkayson Pharma Private Limited is a private limited company based in Pune, Maharashtra, India. It operates in the animal feeds segment of the agriculture sector. It was incorporated on 10 February 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Pune, under CIN U73100PN2017PTC168840. Its GSTIN is 27AAFCV7528N1ZM (Maharashtra).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Rajesh Jagannath Kasunde and Deepa Laxmi Rajesh Kasunde.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Row House No. 59 S. No. 685/3 Bibwewadi, Pune, Maharashtra, India – 411037.
As per the financials filed for FY 2024, the company reported a revenue of ₹1.1 Cr, a growth of 26% compared to the previous year. For the same year it recorded a net profit of ₹5.08 Lakh (net margin 4.6%) and EBITDA of ₹6.24 Lakh (EBITDA margin 5.7%). Revenue has grown at a compounded annual rate (CAGR) of 40% over three years and 54% over five years.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website visinnoremedies.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressRow House No. 59 S. No. 685/3 Bibwewadi, Pune, Maharashtra, India – 411037
- IndustryAgriculture, Animal Feeds
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Rkayson Pharma Private Limited
The main business activity of Rkayson Pharma is professional, scientific and technical activities. In detail, this covers scientific research and development.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| M | Professional, scientific and technical activities | 72 | Scientific research and development | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Rkayson Pharma Private Limited FY 2025 filings available
Rkayson Pharma Private Limited reported revenue of ₹1.1 Cr (up 26% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Rkayson Pharma Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 54% over five years, including 26% growth in the latest year. EBITDA rose 1% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Rkayson Pharma Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹6.24 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹5.08 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Rkayson Pharma Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.7% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 4.6% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Rkayson Pharma are in the company report.
Financial statements from FY 2017
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Rkayson Pharma Private Limited
Rkayson Pharma Private Limited is compared with the companies closest to it by revenue in the Agriculture industry (Animal Feeds). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Aryan Food &Agro Enterprises Private Limited | ₹1.13 Cr (FY 2018) | •••• | •••• | -58.0% | •••• | Patna, Bihar, India |
| Elegance and Soothing Enterprises (India) Private Limited | ₹1.13 Cr (FY 2024) | •••• | •••• | 9.0% | •••• | Aurangabad, Maharashtra, India |
| Nutrivet Food and Feeds Private Limited | ₹1.11 Cr (FY 2025) | •••• | •••• | -52.0% | •••• | Jind, Haryana, India |
| Kalindi Feeds India Private Limited | ₹1.11 Cr (FY 2022) | •••• | •••• | •••• | Deoria, Uttar Pradesh, India | |
| Univision Vet Private Limited | ₹1.1 Cr (FY 2025) | •••• | •••• | -10.0% | •••• | Kolkata, West Bengal, India |
| Rkayson Pharma Private Limited this company | ₹1.1 Cr (FY 2024) | •••• | •••• | 26.0% | •••• | Pune, Maharashtra, India |
| SHRM Bio-Technologies Private Limited | ₹1.1 Cr (FY 2021) | •••• | •••• | 26.0% | •••• | Kolkata, West Bengal, India |
| DPM Agro and Foods Private Limited | ₹1.09 Cr (FY 2024) | •••• | •••• | 1.0% | •••• | Noida, Uttar Pradesh, India |
| Aquamarine Liqua Chem Private Limited | ₹1.09 Cr (FY 2025) | •••• | •••• | 13.0% | •••• | Pune, Maharashtra, India |
| Agventure Industries Private Limited | ₹1.07 Cr (FY 2023) | •••• | •••• | •••• | Chalisgaon, Maharashtra, India | |
| Luay Agro Private Limited | ₹1.05 Cr (FY 2025) | •••• | •••• | •••• | Chennai, Tamil Nadu, India |
Peers are the five companies nearest above and the five nearest below Rkayson Pharma by revenue in the Agriculture industry (Animal Feeds), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Rkayson Pharma Private Limited
Auditor information for Rkayson Pharma Private Limited provides details about the firm responsible for auditing the company's financial statements and ensuring compliance with regulatory requirements.
Board of Directors of Rkayson Pharma Private Limited
Rkayson Pharma has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rajesh Jagannath Kasunde | Director | 10 Feb 2017 | 9 Years 8 Months | Current |
| Deepa Laxmi Rajesh Kasunde | Director | 10 Feb 2017 | 9 Years 8 Months | Current |
Ownership and Shareholding of Rkayson Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Rkayson Pharma Private Limited
Rkayson Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Rkayson Pharma Private Limited
Employment history and EPFO contributions of people linked to Rkayson Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Rkayson Pharma Private Limited
Rkayson Pharma Private Limited has 2 board changes on record since 2017: 2 appointments. The latest: Deepa Laxmi Rajesh Kasunde was appointed as Director on 10 Feb 2017.
Credit Ratings, Litigation & Regulatory Alerts for Rkayson Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Rkayson Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Rkayson Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Rkayson Pharma Private Limited
Rkayson Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAFCV7528N1ZM | Maharashtra | Active | 30 Jul 2019 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Rkayson Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Rkayson Pharma Private Limited
Rkayson Pharma is an active private limited company based in Pune, Maharashtra, India. The company works in animal feeds, within the agriculture industry. It was incorporated on 10 February 2017 (9+ years old) and is registered under CIN U73100PN2017PTC168840.
Rkayson Pharma reported revenue of ₹1.1 Cr for FY 2024 (up 26% YoY).
Rkayson Pharma has 2 current directors:
- Rajesh Jagannath Kasunde - Director
- Deepa Laxmi Rajesh Kasunde - Director
Rkayson Pharma reported a net profit of ₹5.08 Lakh (net margin 4.6%) and EBITDA of ₹6.24 Lakh (EBITDA margin 5.7%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Rkayson Pharma is 40% over three years and 54% over five years. In the latest year (FY 2024) revenue rose 26%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Rkayson Pharma is 27AAFCV7528N1ZM, registered in Maharashtra.
The CIN (Corporate Identification Number) of Rkayson Pharma is U73100PN2017PTC168840. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Rkayson Pharma was incorporated on 10 February 2017, making it 9+ years old. It is registered with the Registrar of Companies, Pune.
The peers of Rkayson Pharma by revenue are Aryan Food &Agro Enterprises Private Limited, Elegance and Soothing Enterprises (India) Private Limited, Nutrivet Food and Feeds Private Limited, Kalindi Feeds India Private Limited, Univision Vet Private Limited and 5 more, all in the Agriculture industry (Animal Feeds).
Deepa Laxmi Rajesh Kasunde was appointed as Director on 10 Feb 2017. Rajesh Jagannath Kasunde was appointed as Director on 10 Feb 2017.
Rkayson Pharma can be reached through the website visinnoremedies.com. Its registered office is in Pune, Maharashtra, India.